Home Page
GALWAY, IRELAND--February 5, 2020--Written by Martin Lynch, European News Editor for Industrial Info (Galway, Ireland)--U.K. pharmaceutical company AstraZeneca is planning to invest $500 million over five years in its French research and manufacturing operations. Within this article: Details investment plans for France over five years, financial performance, sale of drug lines
(All Fields Required)
Site-wide Scheduled Maintenance for September 27, 2025 from 12 P.M. to 6 P.M. CDT. Expect intermittent web site availability during this time period.
×Contact Us
For More Info!
